Characteristics of exopolysaccharides from Paecilomyces hepiali and their simulated digestion and fermentation in vitro by human intestinal microbiota

Int J Biol Macromol. 2024 May;266(Pt 1):131198. doi: 10.1016/j.ijbiomac.2024.131198. Epub 2024 Mar 27.

Abstract

The metabolic process of polysaccharides in gastrointestinal digestions and the effects of the resulting carbohydrates on the composition of gut microbes are important to explore their prebiotic properties. Therefore, the purpose of this study was to investigate the simulated digestion and fecal fermentation in vitro of three fractions (PHEPSs-1, PHEPSs-2 and PHEPSs-3) purified from the crude exopolysaccharides of Paecilomyces hepiali HN1 (PHEPSs) and to explore the potential prebiotic mechanisms. The three purified fractions were characterized by HPLC, UV, FT-IR, SEM and AFM, and they were all of galactoglucomannan family with molecular weight of 178, 232 and 119 kDa, respectively. They could resist the simulated gastrointestinal digestions, but they were metabolized in fecal fermentation in vitro. Furthermore, the mannose in PHEPSs showed a higher utilization rate than that of glucose or galactose. The proliferation effects of PHEPSs on Bifidobacterium and Lactobacillus were weaker significantly than those of fructooligosaccharides before 12 h of fecal fermentation, but stronger after 24 h of fecal fermentation. Meanwhile, higher levels of short-chain fatty acids were found in PHEPSs groups when the fecal fermentation extended to 36 h. Therefore, PHEPSs are expected to have a potent gut healthy activity and can be explored as functional food ingredients.

Keywords: Exopolysaccharides; Fecal fermentation; Paecilomyces hepiali HN1; Stimulated digestion.

MeSH terms

  • Digestion*
  • Feces / microbiology
  • Fermentation*
  • Fungal Polysaccharides / chemistry
  • Fungal Polysaccharides / pharmacology
  • Gastrointestinal Microbiome*
  • Humans
  • Paecilomyces* / metabolism
  • Prebiotics

Substances

  • Fungal Polysaccharides
  • Prebiotics